Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2006-10-12
2010-06-22
Long, Scott (Department: 1633)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S366000, C424S422000, C424S093700
Reexamination Certificate
active
07741117
ABSTRACT:
The present invention is directed to methods of switching a differentiation of a cell from a non-osteogenic lineage into an osteogenic lineage. The present invention is also directed to methods of generating a model system for assessing the intracellular signaling pathways of bone growth factors.
REFERENCES:
patent: 5504192 (1996-04-01), Gill et al.
patent: 6300127 (2001-10-01), Hair et al.
patent: 7517866 (2009-04-01), Boden
patent: 2003/0180266 (2003-09-01), McKay et al.
patent: 2003/0225021 (2003-12-01), McKay et al.
patent: 2004/0264853 (2004-12-01), Schwarz et al.
patent: 2005/0112168 (2005-05-01), Puzas
patent: 2006/0276386 (2006-12-01), Chantry et al.
patent: 2007/0027081 (2007-02-01), Marx et al.
patent: WO2005/016368 (2005-02-01), None
Bruder et al. (Journal of Cellular Biochemistry, 1994. vol. 56(3): 283-294).
Boden et al. (Endocrinology 1998; 139(12): 5125-5134).
Alden et al., “Bone morphogenetic protein gene therapy for the induction of spinal arthodesis,”; Neurosurgical Focus; 1998, vol. 4, Article 12.
Boden et al., Differential effects and glucocorticoid potentiation of bone morphogenetic protein action durign rat osteoblast differentiation in vitro,; Endocrinology; vol. 137, No. 8, pp. 3401-3407.
Boden et al., “LMP-1, A LIM-Domain protein, mediates BMP-6 effects on bone formation,”; Endocrinology; vol. 139, No. 12, pp. 5125-5134.
Boden et al., “Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6,”; Endocrinology; vol. 138, No. 7, pp. 282.
Ying et al., “Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting smad5 for degradation,”; The Journal of Biological Chemistry; Oct. 3, 2003; vol. 278, No. 49, pp. 39029-39036.
Zhao et al., “Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo,”; The Journal of Biological Chemistry; Mar. 26, 2004; vol. 279, No. 13, pp. 12854-12859.
Murakami et al., “Cooperative inhibition of bone morphogenetic protein signaling by smurf1 and inhibitory smads,”; Molecular Biology of the Cell; 2003; vol. 14, pp. 2809-2817.
Sangadala et al., “LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with smurf1 resulting in decreased ubiquitination of smads,”; The Journal of Biological Chemistry; Jun. 23, 2006; vol. 281, No. 25, pp. 17212-17219.
Katagiri T et al: “Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.” The Journal of Cell Biology, vol. 127, No. 6 Pt 1, Dec. 1994, pp. 1755-1766, XP000611930, ISSN: 0021-9525.
Yang Min et al: “Adeno-associated virus-mediated bone morphogenetic protein-7 gene transfer induces C2C12 cell differentiation into osteoblast lineage cells.” Acta Pharmacologica Sinica, vol. 26, No. 8, Aug. 2005, pp. 963-968, XP002491932, ISSN: 1671-4083.
Gersbach C A et al: “Runx2/Cbfal stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype.” Experimental Cell Research, vol. 300, No. 2, Nov. 1, 2004, pp. 406-417, XP004592428, ISSN: 0014-4827.
Gu Keni et al: “Identification of potential modifiers of Runx2/Cbfal activity in C2C12 cells in response to bone morphogenetic protein-7.” Cells, Tissues, Organs, vol. 176, No. 1-3, 2004, pp. 28-40, XP008087399 ISSN: 1422-6405.
Chandra A et al: “Neurogenesin-1 differentially inhibits the osteoblastic differentiation by bone morphogenetic proteins in C2C12 cells.” Biochemical and Biophysical Research Communications, vol. 344, No. 3, Jun. 9, 2006, pp. 786-791, XP005404773, ISSN: 0006-291X.
Sangadala S et al: “LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurfl resulting in decreased ubiquitination of Smads.” The Journal of Biological Chemistry, vol. 281, No. 25, Jun. 23, 2006, pp. 17212-17219, XP002491933, ISSN: 0021-9258 cited in the application the whole document.
Liu Yunshan et al: “Overexpressed LIM mineralization proteins do not require LIM domains to induce bone.”Journal of Bone and Mineral Research, vol. 17, No. 3, Mar. 2003, pp. 406-414, XP002491934, ISSN: 0084-0431 cited in the application the whole document.
Fei Qinming et al: “Truncated human LMP-1 triggers differentiation of C2C12 cells to an osteoblastic phenotype in vitro.” Acta Biochimica et Biophysica Sinica, vol. 39, No. 9, Sep. 2007, pp. 693-700, XP002491935 ISSN: 1672-9145 the whole document.
Sangadala S et al: “Modeling and analysis of molecular interaction between Smurfl-WW2 domain and various isoforms of LIM mineralization protein” Proteins Structure Function and Bioinformatics, vol. 68, No. 3, Aug. 2007, pp. 690-701, XP002491936, ISSN: 0887-3585.
Boden Scott D.
Sangadala Sreedhara
Titus F. Louisa
Emory University
Long Scott
LandOfFree
Bone mineralization protein expression systems, and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bone mineralization protein expression systems, and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bone mineralization protein expression systems, and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4194624